68
Participants
Start Date
August 29, 2019
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Total-Body Irradiation
Undergo TBI
Thiotepa
Given IV
Fludarabine
Given IV
Cyclophosphamide
Given IV
Busulfan
Given IV
Allogeneic Bone Marrow Transplantation
Receive unmanipulated T cell replete BM
Tacrolimus
Given IV
Methotrexate
Given IV
Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation
Receive naive T-cell depleted PBSCs
Echocardiography
Undergo ECHO
Biospecimen Collection
Undergo CSF and blood sample collection
Bone Marrow Aspiration
Undergo bone marrow aspiration
Bone Marrow Biopsy
Undergo bone marrow biopsy
RECRUITING
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
NOT_YET_RECRUITING
Children's Healthcare of Atlanta, Atlanta
NOT_YET_RECRUITING
UH Rainbow Babies and Children's Hospital (University Hospitals Cleveland Medical Center), Cleveland
RECRUITING
Cleveland Clinic Foundation, Cleveland
RECRUITING
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
RECRUITING
Children's Hospital of Los Angeles, Los Angeles
RECRUITING
Oregon Health and Science University, Portland
RECRUITING
Fred Hutch/University of Washington Cancer Consortium, Seattle
WITHDRAWN
Children's National Medical Center, Washington D.C.
NOT_YET_RECRUITING
Dana Farber / Boston Children's Hospital, Boston
National Cancer Institute (NCI)
NIH
Fred Hutchinson Cancer Center
OTHER